Kura Oncology Stock News

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) Catalent Inc (NYSE: CTLT) CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...

Today, we take an in-depth look at Kura Oncology. The company is advancing a couple of late-stage pipeline assets.

– Anticipate preliminary data presentation of menin inhibitor program, KO-539, at ASH – – Continued progress in registration-directed trial of tipifarnib in HRAS mutant HNSCC –– Opportunity

SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cance

A look at the shareholders of Kura Oncology, Inc. (NASDAQ:KURA) can tell us which group is most powerful. Institutions...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes

Kura Oncology (NASDAQ:KURA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, �

Squarepoint Ops LLC lessened its holdings in Kura Oncology Inc (NASDAQ:KURA) by 29.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commissi

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Citigroup Inc. raised its stake in Kura Oncology Inc (NASDAQ:KURA) by 68.9% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 21,798 shares of the company�

SAN DIEGO, June 11, Jun 11, 2020 (GLOBE NEWSWIRE via COMTEX) -- SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a...

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced updated clinical outcome d

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) ADC Therapeutics SA (NYSE:...